# Safety and Efficacy in Adult Subjects With Acute Migraines

> **NCT03237845** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1499 (actual)

## Conditions studied

- Migraine, With or Without Aura

## Interventions

- **DRUG:** Rimegepant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03237845
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-27
- **Primary completion:** 2018-01-25
- **Final completion:** 2018-01-31
- **Target enrollment:** 1499 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237845, "Safety and Efficacy in Adult Subjects With Acute Migraines". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03237845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*